WO2017216696A1 - Determining blood type by tube facilitated - Google Patents
Determining blood type by tube facilitated Download PDFInfo
- Publication number
- WO2017216696A1 WO2017216696A1 PCT/IB2017/053447 IB2017053447W WO2017216696A1 WO 2017216696 A1 WO2017216696 A1 WO 2017216696A1 IB 2017053447 W IB2017053447 W IB 2017053447W WO 2017216696 A1 WO2017216696 A1 WO 2017216696A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tubes
- blood
- tube
- results
- coefficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/15003—Source of blood for venous or arterial blood
Definitions
- the innovation refers to Medicine, biomedical engineering, Hygiene; Detecting, measuring or recording for diagnostic purposes; Investigating or analyzing materials by specific methods not covered by the preceding groups.
- Tube method Blood typing test was formerly done on specific slides that is now considered obsolete and illegal. Afterwards, the tube method was substituted that is a safer and more scientific method. In tube method “three” tubes are used to determine the blood type that is, a scientific and international method. Moreover, instead of vibrating the slides on the shaker, after adding reagent antibodies, the tubes are placed in centrifuges with specific revolutions and time and then, proceed to perusal and interpret the results using eyesight and related cadre.
- the second and primary problem that occurs in laboratories and institutes of blood transfusion is that for each person the blood typing is performed, e.g. likely the blood typing of 5, 10, 30 or even more persons are simultaneously done.
- each of the three tubes are designed in one tube and for each of distinct spaces a hole is embedded to spill the blood and reagents of blood typing.
- reagent A is always poured into the first cell and human mind gets used to it and a series of human errors get eliminated.
- Using a tube for each person decreases the errors, besides.
- the place of pouring blood, reagents, and also tubes are numbered so that after centrifuging the tubes each tube is placed on its former position which has the name and number of that particular person.
- the box is cuboid which has 8 holes for placing each person’s sample before and after centrifuging and there are 8 holes to place each person’s test tube.
- the box is designed to be additionally responsive for some of the serology slide tests and be usable for slide method if needed to immediately re-verify blood typing results which is a very important property.
- the confidence coefficient will increase significantly since the major proportion of errors are due to this matter. For instance, the responding occurs after authentic reading of reply during writing the results in the sheet or reception to the system. Thus, re-check of result readings is possible without fully redoing the test and spending more expenses and work force.
- the patient’s blood sample is placed in first cell. Then the special tube, that is numbered, is placed on the right hand and besides the person’s blood sample. Moreover, the required amount of blood is taken and poured into one the three spaces using the sampler.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Ecology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (8)
- Three required tubes for this experiment are placed and designed in one tube to avoid the confusion due to the number of tubes and with conditioning due to consistency and repetition of work stages, coefficient of error decreases. In addition to accuracy and authenticity of results, the pace is also improved.
- Using this method, decreasing the tubes will lead to reduction of coefficient of error.
- Applicability for both methods, cell type and back type.
- Because of the one-piece tube for each person, the pace and accuracy rises simultaneously and lesser space is needed, besides. Any decrease of mistaken blood typing will increase the coefficient of patient’s safety whom are nominated for blood reception and transplantation since the coincidence of patient’s and donor blood type will 99% fulfill the recipient
- Because of the possibility of verifying and controlling the authenticity of results via a second person, the confidence coefficient will increase significantly since the major proportion of errors are due to this matter. For instance, the responding occurs after authentic reading of reply during writing the results in the sheet or reception to the system. Thus, recheck of result readings is possible without fully redoing the test and spending more expenses and work force.
- Since no redoing of the test is required when suspicious of results of reading and interpreting, the need for redoing the test is omitted and eventually further expenses reduce dramatically.
- Amplifying the patient safety to blood products
- Tube with separation to 3 distinct parts
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IR13953003475 | 2016-06-15 | ||
| IR139550140003003475 | 2016-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2017216696A1 true WO2017216696A1 (en) | 2017-12-21 |
Family
ID=83268085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2017/053447 Ceased WO2017216696A1 (en) | 2016-06-15 | 2017-06-10 | Determining blood type by tube facilitated |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2017216696A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0203930B1 (en) * | 1984-11-13 | 1990-07-11 | Cedars-Sinai Medical Center | Portable blood typing apparatus and method |
| WO1995031731A1 (en) * | 1994-05-17 | 1995-11-23 | Gamma Biologicals, Inc. | Method and apparatus useful for detecting bloodgroup antigens and antibodies |
-
2017
- 2017-06-10 WO PCT/IB2017/053447 patent/WO2017216696A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0203930B1 (en) * | 1984-11-13 | 1990-07-11 | Cedars-Sinai Medical Center | Portable blood typing apparatus and method |
| WO1995031731A1 (en) * | 1994-05-17 | 1995-11-23 | Gamma Biologicals, Inc. | Method and apparatus useful for detecting bloodgroup antigens and antibodies |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Torlakovic et al. | Getting controls under control: the time is now for immunohistochemistry | |
| US9101926B2 (en) | Method for separating a sample into density specific fractions | |
| der Strate et al. | Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis Forum | |
| US20130045852A1 (en) | Centrifuge separation method and apparatus using a medium density fluid | |
| US10895570B2 (en) | Method for determining the result of an agglutination reaction and microplate for determining products of agglutination reactions | |
| IL274377B2 (en) | Cartridge and system for analyzing body liquid | |
| CN101493456B (en) | Diluent wells produced in card format for immunodiagnostic testing | |
| CN108226536A (en) | The micro-fluidic immune detection chip and method of a kind of cardiac muscle troponin I | |
| WO2017216696A1 (en) | Determining blood type by tube facilitated | |
| Roberts et al. | Solid‐phase assays for the detection of alloantibody against human leukocyte antigens: Panacea or Pandora? | |
| US20130122606A1 (en) | Method and device for chemical and/or biological analysis | |
| Sarkar et al. | Assessment of platelet function by automated light transmission aggregometry | |
| CN107462724A (en) | The detection method of circulating tumor cell in blood | |
| JP5220466B2 (en) | HLA antibody analysis apparatus, method and program thereof | |
| Judd et al. | Reactivity of FDA-approved anti-D reagents with partial D red blood cells | |
| AU2016223431B2 (en) | Antibody detection method and system | |
| Roback et al. | Performance and reliability of a benchtop automated instrument for transfusion testing: a comparative multicenter clinical study in the US population | |
| Mihalko et al. | Microfluidics in assessing platelet function | |
| JPH09507577A (en) | Reaction column and method for multi-target simultaneous measurement | |
| WO2020146826A1 (en) | Device & method for saliva-based analyte testing | |
| Weinstein et al. | Blood typing and cross‐matching | |
| JP6331524B2 (en) | Standard cell solution | |
| CN105973825B (en) | A kind of whole blood biochemistry detection method and device | |
| Setyanda et al. | Screening and identification of erythrocyte antibodies: a narrative literature review | |
| Roberts | Antibody titration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17812845 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 17812845 Country of ref document: EP Kind code of ref document: A1 |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC. EPO FORM 1205A DATED 09.07.19 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 17812845 Country of ref document: EP Kind code of ref document: A1 |